Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pediatrix Medical (MD) Non Operating Income (2016 - 2026)

Pediatrix Medical (MD) has disclosed Non Operating Income for 13 consecutive years, with -$3.2 million as the latest value for Q4 2025.

  • Quarterly Non Operating Income rose 46.35% to -$3.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.6 million through Dec 2025, up 123.35% year-over-year, with the annual reading at $7.6 million for FY2025, 123.35% up from the prior year.
  • Non Operating Income for Q4 2025 was -$3.2 million at Pediatrix Medical, down from $19.7 million in the prior quarter.
  • The five-year high for Non Operating Income was $19.7 million in Q3 2025, with the low at -$67.5 million in Q1 2022.
  • Average Non Operating Income over 5 years is -$12.0 million, with a median of -$9.0 million recorded in 2023.
  • The sharpest move saw Non Operating Income crashed 233.09% in 2023, then surged 329.6% in 2025.
  • Over 5 years, Non Operating Income stood at -$14.5 million in 2021, then soared by 43.31% to -$8.2 million in 2022, then plummeted by 233.09% to -$27.4 million in 2023, then soared by 78.21% to -$6.0 million in 2024, then surged by 46.35% to -$3.2 million in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods came in at -$3.2 million, $19.7 million, and -$4.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.